Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Sep;82(3):885–894. doi: 10.1172/JCI113694

Role of central alpha-1 adrenoceptors in canine narcolepsy.

E Mignot 1, C Guilleminault 1, S Bowersox 1, A Rappaport 1, W C Dement 1
PMCID: PMC303598  PMID: 2843574

Abstract

The role of central alpha-1 adrenergic receptors in cataplexy was investigated in genetically narcoleptic Doberman pinschers. Treatment of narcoleptic dogs with 25-600 micrograms/kg prazosin, a selective alpha-1 adrenergic receptor blocker, exacerbated cataplexy, whereas treatment with the alpha-1 agonist, methoxamine, ameliorated it. Subsequent studies showed that the beneficial effects of classical treatments of human narcolepsy (amphetamines and tricyclic antidepressants) are antagonized by prazosin, suggesting that these drugs are active through an indirect alpha-1 stimulation (via an increase of norepinephrine in the synaptic cleft). Other studies confirmed that the observed effects were not due to peripheral alpha-1 cardiovascular involvement. Atropine, a central anticholinergic agent, but not methylatropine, a peripheral one, completely suppressed the prazosin effect, which suggests that adrenergic and cholinergic systems act sequentially and not independently to generate cataplexy. Little is known about the physiological role of central alpha-1 adrenoceptors. This series of experiments implicates these receptors in narcolepsy-cataplexy.

Full text

PDF
885

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ECKSTEIN J. W., ABBOUD F. M. Circulatory effects of sympathomimetic amines. Am Heart J. 1962 Jan;63:119–135. doi: 10.1016/0002-8703(62)90230-2. [DOI] [PubMed] [Google Scholar]
  2. Greengrass P., Bremner R. Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors. Eur J Pharmacol. 1979 May 1;55(3):323–326. doi: 10.1016/0014-2999(79)90202-4. [DOI] [PubMed] [Google Scholar]
  3. Hartmann E., Chung R., Draskoczy P. R., Schildkraut J. J. Effects of 6-hydroxydopamine on sleep in the rat. Nature. 1971 Oct 8;233(5319):425–427. doi: 10.1038/233425a0. [DOI] [PubMed] [Google Scholar]
  4. Hartmann E., Zwilling G. The effect of alpha and beta adrenergic receptor blockers on sleep in the rat. Pharmacol Biochem Behav. 1976 Aug;5(2):135–138. doi: 10.1016/0091-3057(76)90028-9. [DOI] [PubMed] [Google Scholar]
  5. Hilakivi I., Leppävuori A. Effects of methoxamine, and alpha-1 adrenoceptor agonist, and prazosin, an alpha-1 antagonist, on the stages of the sleep-waking cycle in the cat. Acta Physiol Scand. 1984 Mar;120(3):363–372. doi: 10.1111/j.1748-1716.1984.tb07396.x. [DOI] [PubMed] [Google Scholar]
  6. Hobson J. A., Goldberg M., Vivaldi E., Riew D. Enhancement of desynchronized sleep signs after pontine microinjection of the muscarinic agonist bethanechol. Brain Res. 1983 Sep 19;275(1):127–136. doi: 10.1016/0006-8993(83)90424-9. [DOI] [PubMed] [Google Scholar]
  7. Jouvet M. Biogenic amines and the states of sleep. Science. 1969 Jan 3;163(3862):32–41. doi: 10.1126/science.163.3862.32. [DOI] [PubMed] [Google Scholar]
  8. Kaitin K. I., Kilduff T. S., Dement W. C. Evidence for excessive sleepiness in canine narcoleptics. Electroencephalogr Clin Neurophysiol. 1986 Nov;64(5):447–454. doi: 10.1016/0013-4694(86)90078-7. [DOI] [PubMed] [Google Scholar]
  9. Kaitin K. I., Kilduff T. S., Dement W. C. Sleep fragmentation in canine narcolepsy. Sleep. 1986;9(1 Pt 2):116–119. doi: 10.1093/sleep/9.1.116. [DOI] [PubMed] [Google Scholar]
  10. Kushida C. A., Baker T. L., Dement W. C. Electroencephalographic correlates of cataplectic attacks in narcoleptic canines. Electroencephalogr Clin Neurophysiol. 1985 Jul;61(1):61–70. doi: 10.1016/0013-4694(85)91073-9. [DOI] [PubMed] [Google Scholar]
  11. Leinonen L., Stenberg D. Sleep in Macaca arctoides and the effects of prazosin. Physiol Behav. 1986;37(2):199–202. doi: 10.1016/0031-9384(86)90221-0. [DOI] [PubMed] [Google Scholar]
  12. Menkes D. B., Aghajanian G. K., Gallager D. W. Chronic antidepressant treatment enhances agonist affinity of brain alpha 1-adrenoceptors. Eur J Pharmacol. 1983 Jan 28;87(1):35–41. doi: 10.1016/0014-2999(83)90047-x. [DOI] [PubMed] [Google Scholar]
  13. Menon M. K., Kodama C. K., Kling A. S., Fitten J. An in vivo pharmacological method for the quantitative evaluation of the central effects of alpha 1 adrenoceptor agonists and antagonists. Neuropharmacology. 1986 May;25(5):503–508. doi: 10.1016/0028-3908(86)90175-9. [DOI] [PubMed] [Google Scholar]
  14. Monti J. M. Minireview. Catecholamines and the sleep-wake cycle. II. REM sleep. Life Sci. 1983 Mar 28;32(13):1401–1415. doi: 10.1016/0024-3205(83)90905-0. [DOI] [PubMed] [Google Scholar]
  15. Nozaki M., Bell J. A., Martin W. R. Noradrenergic action of amphetamine following degeneration of descending monoaminergic fibers in the spinal cord. Psychopharmacology (Berl) 1980 Jan;67(1):25–29. doi: 10.1007/BF00427591. [DOI] [PubMed] [Google Scholar]
  16. Oswald I., Thacore V. R., Adam K., Brezinová V. Apha-adrenergic receptor blockade increases human REM sleep. Br J Clin Pharmacol. 1975 Apr;2(2):107–110. doi: 10.1111/j.1365-2125.1975.tb01565.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pellejero T., Monti J. M., Baglietto J., Jantos H., Pazos S., Cichevski V., Hawkins M. Effects of methoxamine and alpha-adrenoceptor antagonists, prazosin and yohimbine, on the sleep-wake cycle of the rat. Sleep. 1984;7(4):365–372. doi: 10.1093/sleep/7.4.365. [DOI] [PubMed] [Google Scholar]
  18. Pichler L., Kobinger W. Possible function of alpha 1-adrenoceptors in the CNS in anaesthetized and conscious animals. Eur J Pharmacol. 1985 Jan 8;107(3):305–311. doi: 10.1016/0014-2999(85)90255-9. [DOI] [PubMed] [Google Scholar]
  19. Pickworth W. B., Sharpe L. G., Nozaki M., Martin W. R. Sleep suppression induced by intravenous and intraventricular infusions of methoxamine in the dog. Exp Neurol. 1977 Dec;57(3):999–1011. doi: 10.1016/0014-4886(77)90123-6. [DOI] [PubMed] [Google Scholar]
  20. Stanaszek W. F., Kellerman D., Brogden R. N., Romankiewicz J. A. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs. 1983 Apr;25(4):339–384. doi: 10.2165/00003495-198325040-00002. [DOI] [PubMed] [Google Scholar]
  21. Starke K. Alpha-adrenoceptor subclassification. Rev Physiol Biochem Pharmacol. 1981;88:199–236. [PubMed] [Google Scholar]
  22. Young W. S., 3rd, Kuhar M. J. Noradrenergic alpha 1 and alpha 2 receptors: light microscopic autoradiographic localization. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1696–1700. doi: 10.1073/pnas.77.3.1696. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES